Skip to main content
. 2022 Sep 26;12:1004974. doi: 10.3389/fonc.2022.1004974

Table 3.

Intraoperative data and surgical effectiveness in the OS and LS groups.

Variables OS group (n = 32) LS group (n = 16) P value
Operative time (mean ± SD, min) 407.97 ± 76.06 489.69 ± 79.17 0.001
Blood loss [median (q1-q3), mL] 600(400-800) 300(200-400) 0.012
Intraoperative blood transfusion, n (%) 24(75) 8(50) 0.083
Hepatectomy 0.838
 Left hemihepatectomy + hepatectomy, n (%) 17 (53.12) 13 (56.25)
 Right hemihepatectomy + hepatectomy, n (%) 15 (46.88) 6 (43.75)
Resection margin, n (%) 0.867*
 R0 28 (87.5) 15 (93.75)
 R1 4 (12.5) 1 (6.25)
Vascular resection and reconstruction, n (%) 2 (6.25) 1 (6.25) 0.527*
Complications, n (%)
 Clavien-Dindo grade < 3 25 (78.12) 14(87.5) 0.695*
 Clavien-Dindo grade ≥ 3 7(21.88) 2(12.5)
 Incision infection 1 (3.12) 1 (6.25) 0.798*
 Gastrointestinal hemorrhage 0 (0) 0 (0) 1.000*
 Intra-abdominal hemorrhage 1(3.13) 0 (0) 0.721*
 Delayed gastric emptying 2 (6.25) 1 (6.25) 0.527*
 Pleural effusion 3 (9.38) 1 (6.25) 0.854*
 Ascites 2 (6.25) 1 (6.25) 0.527*
 Pulmonary infection 3 (9.38) 2 (12.5) 0.867*
 Abdominal infection 2 (6.25) 1 (6.25) 0.527*
 Liver failure 0 (0) 0 (0) 1.000*
 Bile leakage 0 (0) 0 (0) 1.000*
 Post-operative hospital stay [median (q1-q3),day] 14(11.25-21.25) 11.5(10.00-17.75) 0.254*
 30-day readmission rate, n (%) 4 (12.5) 1 (6.25) 0.867*
 90-day mortality rate, n (%) 1 (3.12) 0 (0) 0.721*
Hospitalization expenses [median (q1-q3),RMB] 95697(80306.25-117588.33) 105170(98160.05-119130) 0.213

Data are presented as standard deviation (mean ± SD) or as number (percentage). * Fisher’s exact test. OS, open surgery; LS, laparoscopic surgery.